About: http://webisa.webdatacommons.org/164921630

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	candidates with some or each of these advantages, the FDA and other regulatory agencies could reject marketing approval of these drug candidates for other reasons, including safety and benefit
http://www.w3.org/ns/prov#wasQuotedFrom	financialcontent.com